In particular, breast cancer molecular subtypes are simplified into three categories based on the IHC evaluation of three key biomarkers: estrogen receptor (ER) expression, progesterone receptor (PR) expression, and HER2 overexpression. This evidence concerns the gene PGR and breast cancer.